UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
COMMUNITY MEDICAL TRANSPORT, INC.
(Name of Issuer)
Common Stock, $.001 par value
(Title of Class of Securities)
203744 10 7
(CUSIP Number)
Michael A. Duchesneau, MD
4015 Bayshore Blvd. #16E
Tampa, FL 33611
813-805-2938
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 4,2000
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition that is the subject of
this Schedule 13D, and is filing this schedule because of
240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box. [ ]
1. Name of Reporting Person
Michael A. Duchesneau, MD
2. Check the appropriate box if a member of a group
(a) [ ] (b) [ ]
3. SEC Use Only
4. Source of Funds
PF
5. Check if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) or 2(e) [ ]
6. Citizenship or Place of Organization
United States of America
Number of Shares Beneficially Owned by Each Reporting Person
With:
7. Sole Voting Power 68,000
8. Shared Voting Power None
9. Sole Dispositive Power 68,000
10. Shared Dispositive Power None
11. Aggregate Amount Beneficially Owned by Each Reporting Person
68,000 Shares
12. Check if the Aggregate Amount in Row (11) Excludes Certain
Shares [ ]
13. Percent of Class Represented by Amount in Row (11)
6.7%
14. Type of Reporting Person
IN
Item 1 SECURITY AND ISSUER
This statement, filed on Schedule 13D, relates to shares of the
Common Stock, $.001 par value, of Community Medical Transport,
Inc., a Delaware Corporation whose principal executive offices
are located at 4 Gannett Drive, White Plains, NY 10604.
Item 2 IDENTITY AND BACKGROUND
This statement is filed on behalf of Michael A. Duchesneau, MD.
Dr. Duchesneau is a citizen of the United States of America and
his primary address is 4015 Bayshore Blvd. #16E Tampa, FL 33611
Dr. Duchesneau is an EMS Physician based in Tampa, FL and New
York City.
During the last five years Dr. Duchesneau has not been convicted
in a criminal proceeding (excluding traffic violations or
similar misdemeanors).
During the last five years Dr. Duchesneau has not been a party
to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or
is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject
to, Federal or State securities laws or finding any violation
with respect to such laws.
Item 3 SOURCE OF FUNDS OR OTHER CONSIDERATION
Dr. Duchesneau has purchased the Common Shares of Community
Medical Transport, Inc., reported herein, on the open market
using personal funds in the amount of $114,631.
Item 4 PURPOSE OF TRANSACTION
Dr. Duchesneau acquired the Common Shares of Community Medical
Transport, Inc., reported herein, as an investment.
(a) Dr. Duchesneau intends to continuously review the
operational performance of Community Medical Transport,
Inc. and the performance of the securities of Community
Medical Transport, Inc., either on the NASDAQ Stock Market,
or through any other markets or sources through which this
Registered Security may be lawfully traded or exchanged.
He reserves the right to purchase additional Common Shares
or any other investment product of Community Medical
Transport, Inc. either on the open market or through any
other lawfully permitted means, or to sell said investment
products on the open market or through any other lawfully
permitted means.
(b) Dr. Duchesneau does not currently have plans for any
extraordinary corporate transaction as defined in Rule 13D,
but he reserves the right to take any lawful action in the
future as he may deem appropriate.
(c) Dr. Duchesneau does not currently have plans for a sale or
transfer of a material amount of assets of the issuer or any
of its subsidiaries, but he reserves the right to take any
lawful action in the future as he may deem appropriate.
(d) Dr. Duchesneau reserves the right to seek a position on the
Board of Directors of Community Medical Transport, Inc.
should he deem it appropriate.
(e) Dr. Duchesneau does not currently have plans for any
material change in the present capitalization or dividend
policy of the issuer, but he reserves the right to take any
lawful action in the future as he may deem appropriate.
(f) Dr. Duchesneau does not currently have plans for any other
material changes in the issuers business or corporate
structure including but not limited to, if the issuer is a
registered closed-end investment company, any plans or
proposals to make any changes in its investment policy for
which a vote is required by section 13 of the Investment
Company Act of 1940.
(g) Dr. Duchesneau does not currently have plans for any changes
in the issuers charter, bylaws or instruments corresponding
thereto or other actions which may impede the acquisition of
control of the issuer by any person, but he reserves the
right to take any lawful action in the future as he may deem
appropriate.
(h) Dr. Duchesneau does not currently have plans that would
cause a class of securities of the issuer to be delisted
from a national securities exchange or to cease to be
authorized to be quoted in an inter-dealer quotation system
of a registered national securities association, but he
reserves the right to take any lawful action in the future
as he may deem appropriate.
(i) Dr. Duchesneau does not currently have plans that would
cause a class of equity securities of the issuer to become
eligible for termination of registration pursuant to Section
12(g)(4) of the Act.
(j) Dr. Duchesneau does not currently have plans that would
result in any action similar to any of those enumerated
above, but he reserves the right to take any lawful action
in the future as he may deem appropriate.
Item 5 INTEREST IN SECURITIES OF THE ISSUER
(a) Dr. Duchesneau directly owns 68,000 shares of the issuers
common stock. Pursuant to Form 10-QSB/A dated November
16,1999 there were 1,015,947 shares of common stock
outstanding as of September 30,1999.
Dr. Duchesneaus holdings thus constitute 6.7% of the
outstanding shares of common stock of the issuer.
(b) Dr. Duchesneau has sole voting and dispositive power over
68,000 common shares of the issuer.
(c) Dr. Duchesneau purchased 68,000 shares of the Common Stock
of the issuer on the open market between the dates of
10/22/1999 and 02/10/2000 at prices from $1.12 to $2.31 per
share.
(d) Not applicable
(e) Not applicable
Item 6 CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS
WITH RESPECT TO SECURITIES OF THE ISSUER
Dr. Duchesneau has no contracts, arrangements, understandings or
relationships (legal or otherwise) with any other person with
respect to any securities of the issuer, including, but not
limited to transfer or voting of any of the securities, finders
fees, joint ventures, loan or option arrangements, puts or
calls, guarantees of profits, division of profits or loss, or
the giving or withholding of proxies.
Item 7 MATERIAL TO BE FILED AS EXHIBITS
None
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete, and correct.
Dated February 10,2000
By /s/ Michael A. Duchesneau, MD
Print Name Michael A. Duchesneau, MD
